PMC:7381711 / 1122-1264 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T7","span":{"begin":98,"end":105},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma82839"}],"text":"adverse effects and theoretical off-target effects that may temper enthusiasm for the adoption of heparin as a therapy in COVID-19 without con"}

{"project":"LitCovid-PubTator","denotations":[{"id":"31","span":{"begin":98,"end":105},"obj":"Chemical"},{"id":"40","span":{"begin":67,"end":77},"obj":"Disease"},{"id":"41","span":{"begin":122,"end":130},"obj":"Disease"}],"attributes":[{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D006493"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"adverse effects and theoretical off-target effects that may temper enthusiasm for the adoption of heparin as a therapy in COVID-19 without con"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T16","span":{"begin":122,"end":130},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"adverse effects and theoretical off-target effects that may temper enthusiasm for the adoption of heparin as a therapy in COVID-19 without con"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T6","span":{"begin":109,"end":110},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"adverse effects and theoretical off-target effects that may temper enthusiasm for the adoption of heparin as a therapy in COVID-19 without con"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":98,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_28304"}],"text":"adverse effects and theoretical off-target effects that may temper enthusiasm for the adoption of heparin as a therapy in COVID-19 without con"}